These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8894572)

  • 1. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction.
    Hall G; Heimdahl A; Nord CE
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):646-9. PubMed ID: 8894572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia.
    Hall G; Hedström SA; Heimdahl A; Nord CE
    Clin Infect Dis; 1993 Aug; 17(2):188-94. PubMed ID: 8399865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis.
    Hall G; Nord CE; Heimdahl A
    J Antimicrob Chemother; 1996 Apr; 37(4):783-95. PubMed ID: 8722544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures.
    Lockhart PB; Brennan MT; Kent ML; Norton HJ; Weinrib DA
    Circulation; 2004 Jun; 109(23):2878-84. PubMed ID: 15173031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient bacteremia after tooth extraction with intravenous cefuroxime prophylaxis.
    Nohara T; Kobayashi I
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):257-9. PubMed ID: 8956469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia after supragingival scaling and dental extraction: Culture and molecular analyses.
    Reis LC; Rôças IN; Siqueira JF; de Uzeda M; Lacerda VS; Domingues R; Miranda KR; Saraiva RM
    Oral Dis; 2018 May; 24(4):657-663. PubMed ID: 28994220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.
    Diz Dios P; Tomás Carmona I; Limeres Posse J; Medina Henríquez J; Fernández Feijoo J; Alvarez Fernández M
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2996-3002. PubMed ID: 16940094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a chlorhexidine mouthwash on the risk of postextraction bacteremia.
    Tomás I; Alvarez M; Limeres J; Tomás M; Medina J; Otero JL; Diz P
    Infect Control Hosp Epidemiol; 2007 May; 28(5):577-82. PubMed ID: 17464918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A
    Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia associated with toothbrushing and dental extraction.
    Lockhart PB; Brennan MT; Sasser HC; Fox PC; Paster BJ; Bahrani-Mougeot FK
    Circulation; 2008 Jun; 117(24):3118-25. PubMed ID: 18541739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental bacteremia in children.
    Roberts GJ; Holzel HS; Sury MR; Simmons NA; Gardner P; Longhurst P
    Pediatr Cardiol; 1997; 18(1):24-7. PubMed ID: 8960488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftibuten versus cefaclor for the treatment of bronchitis.
    Chirurgi VA; Edelstein H; Oster SE; Karp R; Cassano KB; Aiken S; Krumpe P; McCabe RE
    J Antimicrob Chemother; 1991 Oct; 28(4):577-80. PubMed ID: 1761452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of transient bacteremia following tooth extraction and antibiotic sensitivity of isolated bacteria].
    Szontágh E; Méray J; Nagy E; Füzesi H
    Fogorv Sz; 1994 Jun; 87(6):165-71. PubMed ID: 8026594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
    Tomás I; Alvarez M; Limeres J; Otero JL; Saavedra E; López-Meléndez C; Diz P
    Oral Microbiol Immunol; 2004 Oct; 19(5):331-5. PubMed ID: 15327647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J; Ruoff GE; Jacobson KD
    Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method].
    Kobayashi H; Kawai S; Saito A; Yajima O; Tomizawa M; Nakayama I; Ishikawa K; Tamura M; Ito T; Takeuchi K
    Kansenshogaku Zasshi; 1986 Sep; 60(9):1052-77. PubMed ID: 3100702
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
    Montero L
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():125-31. PubMed ID: 8818853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
    Hyslop DL; Bischoff W
    Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.